Healthcare Sector

On December 12, last year, the company initiated a Class II nationwide (US) recall of the affected lot.

In India, Wipro and GE Healthcare operate as a joint venture.

Deuruxolitinib, Concert's lead candidate, is getting tested as a treatment for the autoimmune condition alopecia areata.

Cidmus tablets are available in three strengths: 50mg, 100mg, and 200mg, and should be taken twice a day.

Temasek plans to invest approximately Rs13,200 crore ($1.6 billion) to acquire an additional 33% stake.

In US Dolutegravir and Rilpivirine Tablets have an estimated annual sales of USD 666 million.

Dr. Reddy's will be in charge of obtaining regulatory approval for Nerivio in India.

Palbociclib is approved for use in combination with hormonal therapies for patients.

NaMuscla is Europe's first and only licensed product for this indication, and it will be commercialized in Spain by Lupin's partner Exeltis.

It has received the Establishment Inspection Report (EIR).